Therapeutic strategies for Huntington's disease based on a molecular understanding of the disorder

Molecular Medicine Today

Volumn 3, Issue 4, 1997, Pages 175-183

  Haque, Nadia S K ^b   Borghesani, Paul ^b   Isacson, Ole ^a  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA GALACTOSIDASE; HUNTINGTIN; NEUROTROPHIC FACTOR;

APOPTOSIS; CELL TRANSPLANTATION; CHROMOSOME 4P; CLINICAL TRIAL; GENE TARGETING; GENE THERAPY; HUMAN; HUNTINGTON CHOREA; NERVE CELL; REVIEW;

HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS;

EID: 0031414142     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01012-5     Document Type: Review

References (44)

1. Greenamyre, J.T. and Shoulson, I. (1994) Huntington's disease, in Neurodegenerative Diseases (Calne, D.B., ed.), pp. 685-704, W.B. Saunders
2. Sharp, A.H. and Ross, C.A. (1996) Neurobiology of Huntington's disease, Neurobiol. Dis. 3, 3-15
3. Perischetti, F. et al. (1995) Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat, Mol. Med. 1, 374-383
4. DiFiglia, M. et al. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons, Neuron 14, 1075-1081
5. Zeitlin, S. et al. (1995) Increased apoptosis and early embryonic lethality in mice nullizygousfor the Huntington's disease gene homologue, Nat. Genet. 11, 155-163
6. Aronin, N. et al. (1995) CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain, Neuron 15, 1193-1201
7. Andrew, S.E. et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease, Nat. Genet. 4, 398-403
8. Wexler, N.S. et al. (1987) Homozygotes for Huntington's disease, Nature 326, 194-197
9. Hoogeveen, A.T. et al. (1993) Characterization and localization of the Huntington disease gene product, Hum. Mol. Genet. 2, 2069-2073
10. Li, S-H. et al. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues, Neuron 11, 985-993
11. Barnes, G.T. et al. (1994) Mouse Huntington's disease gene homolog (HDh), Somat. Cell Mol. Genet. 20, 87-97
12. Bessert, D.A. et al. (1995) The identification of a functional nuclear localization signal in the Huntington disease protein. Mol. Brain Res. 33, 165-173
13. Carlock, L. et al. (1995) Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade, NeuroReport 6, 1121-1124
14. Portera-Cailliau, C., Hedreen, J.C., Price, D.L. and Koliatsos, V.E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models, J. Neurosci. 15, 3775-3787
15. Tatter, S.B. et al. (1995) Effects of striatal excitotoxicity on huntingtin-like immunoreactivity, NeuroReport 6, 1125-1129
16. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons, J. Neurochem. 65, 1740-1751
17. 1H NMR spectroscopy, Neurology 43, 2689-2695
18. Simpson, J.R. and Isacson, O. (1993) Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum, Exp. Neurol. 121, 57-64
19. Gu, M. et al. (1996) Mitochondrial defect in Huntington's disease caudate nucleus, Ann. Neurol. 39, 385-389
20. Dragunow, M. et al. (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, NeuroReport 6, 1053-1057
21. Burke, J.R. et al. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH, Nat. Med. 2, 347-350
22. Ishitani, R. et al. (1996) Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture, J. Neurochem. 66, 928-935
23. Goldberg, Y.P. et al. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract, Nat. Genet. 13, 442-449
24. Ambrose, C.M. et al. (1994) Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat, Somatic Cell Mol. Genet. 20, 27-38
25. Mangiarini, L. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell 87, 493-506
26. Duyao, M.P. et al. (1995) Inactivation of the mouse Huntington's disease gene homolog HDh, Science 269, 407-410
27. Nasir, J. et al. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes, Cell 81, 811-823
28. Rossi, J.J. (1995) Therapeutic antisense and ribozymes, Br. Med. Bull. 51, 217-225
29. Haque, N.S.K. and Isacson, O. Antisense gene therapy for neurodegenerative disease? Exp. Neurol. (in press)
30. Bao, J. et al. (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin, Proc. Natl. Acad. Sci. U. S. A. 93, 5037-5042
31. Li, X-J. et al. (1995) A Huntingtin-associated protein enriched in brain with implications for pathology, Nature 378, 398-402
32. Wang, T. et al. (1996) The p21 (RAS) farnesyltransferase α subunit in TGF-β and activin signaling, Science 271, 1120-1122
33. Isacson, O. et al. (1995) Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigra, Restor. Neurol. Neurosci. 8, 59-61
34. Peyser, C.E. et al. (1995) Trial of D-α-tocopherol in Huntington's disease, Am. J. Psychiatry 152, 1771-1775
35. Isacson, O. et al. (1995) Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres, Nat. Med. 1, 1189-1194
36. Dunnett, S.B. and Svendson, C.N. (1993) Huntington's disease: animal models and transplantation repair, Curr. Opin. Neurobiol. 3, 790-796
37. Friedmann, T. (1996) Human gene therapy - an immature genie, but certainly out of the bottle, Nat. Med. 2, 144-147
38. Pakzaban, P., Geller, A.I. and Isacson, O. (1994) Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain, Hum. Gene Ther. 5, 987-995
39. Smith, F., Jacoby, D. and Breakefield, X.O. (1995) Virus vectors for gene delivery to the nervous system, Restor. Neurol. Neurosci. 8, 21-34
40. Wolff, J.A. et al. (1990) Direct gene transfer into mouse muscle in vivo, Science 247, 1465-1468
41. Jiao, S. et al. (1992) Persistence of plasmid DNA and expression in rat brain cells in vivo, Exp. Neurol. 115, 400-413
42. Dure, L.S. et al. (1994) IT15 gene expression in fetal human brain, Brain Res. 659, 33-41
43. Andrade, M.A. and Bork, P. (1995) HEAT repeats in the Huntington's disease protein, Nat. Genet. 11, 115-116
44. Richfield, E.K. et al. (1995) Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients, Ann. Neurol. 38, 852-861